Aurobindo Pharma Ltd.’s first-quarter profit rose, in-line with analysts’ estimates.The Hyderabad-based bulk and generic drug maker’s net profit rose 10% year-on-year to Rs 571 crore in the quarter ended June, according to an exchange filing. That compares with the Rs 557-crore consensus estimate of analysts tracked by Bloomberg.Sequentially, it rose 13%.
By Saad Sayeed, Ariba Shahid and Steve Holland ISLAMABAD/WASHINGTON, April 25 (Reuters) - Iranian Foreign Minister Abbas Araqchi laid out...
It took less than three minutes for wind-whipped flames to go from licking the side of the house to shattering a window...
Investing.com – Morocco stocks were lower after the close on Thursday, as losses in the , and sectors led shares...
This article was written byFollowJR Research is an opportunistic investor. I was recognized by TipRanks as a Top Analyst, and...
The Map is not the Terrain… https://theideafarm.com/markets/emerging-markets-the-map-is-not-the-terrain/ And also from a recent podcast with La Roche here is Gundlach “”My...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
